French biotech firm Ipsen, which has its Biomeasure division in Milford, announced the opening of a new commercial headquarters in New Jersey.
Ipsen said the move reaffirms its commitment to the pursuit of neurology and endocrinology therapeutics in the United States.
The company’s previous U.S. headquarters was in San Francisco. The relocation will create 100 new jobs for New Jersey. Ipsen said the state’s growing pharmaceutical and biopharmaceutical industries were key factors in its decision relocate there.
